Disrupting the rhythm of depression: Design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Bockting, Claudi L H ^a   Elgersma, Hermien J ^a,b   van Rijsbergen, Gerard D ^a   de Jonge, Peter ^c   Ormel, Johan ^c   Buskens, Erik ^c   Stant, A Dennis ^c   de Jong, Peter J ^a   Peeters, Frenk P M L ^d   Huibers, Marcus J H ^e   Arntz, Arnoud ^e   Muris, Peter ^f   Nolen, Willem A ^c   Schene, Aart H ^g   Hollon, Steven D ^h  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Mental health care center Accare ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; ATTITUDE; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; ECONOMIC EVALUATION; HUMAN; MAJOR CLINICAL STUDY; MEDIATOR; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; REMISSION; RISK FACTOR; STRUCTURED INTERVIEW; SYMPTOM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; MAJOR DEPRESSION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLINICAL PROTOCOLS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FOLLOW-UP STUDIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PSYCHOTHERAPY, BRIEF; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 78651227527     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-8     Document Type: Article

References (49)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:442.
2. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997, 10(349):1347-52.
3. Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Bromet EJ, Burger H, Demyttenaere K, de Girolamo G, Haro JM, Hwang I, Karam E, Kawakami N, Lépine JP, Medina-Mora ME, Posada-Villa J, Sampson N, Scott K, Ustün TB, Von Korff M, Williams DR, Zhang M, Kessler RC. Disability and treatment of specific mental and physical disorders across the world: Results from the WHO World Mental Health Surveys. Br J Psychiatry 2008, 192:368-375. 10.1192/bjp.bp.107.039107, 2681238, 18450663.
4. American Psychiatric Association Practice guidelines for the treatment of psychiatric disorders: Compendium 2008 2008, Washington, D.C, American Psychiatric Association.
5. Clinical NICE Depression Management of depression in primary and secondary care 2009, The National Collaborating Centre for Mental Health, Clinical NICE Depression.
6. Bockting CLH, ten Doesschate MC, Spijker J, Spinhoven P, Schene AH, . the DELTA study group Continuation and maintenance use of antidepressants in recurrent depression. Psychoth Psychosom 2008, 77:17-26. the DELTA study group.
7. Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. European J Clin Pharmacology 2004, 60:57-61.
8. ten Doesschate MC, Bockting CLH, Schene AH. Adherence to continuation and maintenance antidepressant use in recurrent depression. J Clin Psychiatry 2009, 70:63-9. 10.4088/JCP.08m04119, 19192463.
9. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998, 5:293-306. 10.3109/10673229809003578, 9559348.
10. Kaymaz N, van Os J, Loonen AJ, Nolen WA. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008, 69:1423-36. 10.4088/JCP.v69n0910, 19193343.
11. Beck AT. The current state of cognitive therapy: a 40-year retrospective. Arch Gen Psychiatry 2005, 62:953-9. 10.1001/archpsyc.62.9.953, 16143727.
12. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 2007, 75:475-88. 10.1037/0022-006X.75.3.475, 2630051, 17563164.
13. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O'Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive Therapy versus Medications in the Treatment of Moderate to Severe Depression. Arch Gen Psychiatry 2005, 62:409-16. 10.1001/archpsyc.62.4.409, 15809408.
14. Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005, 62:417-27. 10.1001/archpsyc.62.4.417, 15809409.
15. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol 2006, 57:285-315. 10.1146/annurev.psych.57.102904.190044, 16318597.
16. Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, O'Connor E, Seeley J. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Archives Gen Psychiatry 2001, 58:1127-34.
17. Dobson KS, Hollon SD, Dimidijan S, Schmaling KB, Kohlenberg RJ, Gallop R, Rizvi SL, Gollan JK, Dunner DL, Jacobson NS. Randomized trial of behavioral activation, cognitive therapy, and Antidepressant medication in prevention of relapse and recurrence in major depression. J Cons Clin Psychol 2008, 76:468-77.
18. Bockting CLH, Schene AH, Spinhoven P, Koeter MWJ, Wouters LF, Huyser J, Kamphuis JH. Preventing recurrence in recurrent depression using cognitive therapy. J Cons Clin Psychol 2005, 73:647-657.
19. Bockting CLH, Spinhoven P, Koeter MWJ, Schene AH. Long term effects of preventive cognitive therapy in recurrent depression using: 5.5 years follow-up. J Clin Psychiatry 2009, 70:1621-8. 10.4088/JCP.08m04784blu, 20141705.
20. Conradi HJ, de Jonge P, Ormel J. Differential treatment response in depressed patients with multiple prior episodes: CT versus the GP; Cognitive-behavioural therapy v. usual care in recurrent depression. Br J Psychiatry 2008, 193:505-6. 10.1192/bjp.bp.107.042937, 19043158.
21. Bockting CLH. The rhythm of depression: The course of recurrent depression and prevention of relapse using cognitive therapy. PhD thesis 2006, Amsterdam.
22. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004, 161:1872-1876. 10.1176/appi.ajp.161.10.1872, 15465985.
23. Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, Barrett B, Byng R, Evans A, Mullan E, Teasdale JD. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 2008, 76:966-978. 10.1037/a0013786, 19045965.
24. de Jong PJ, Pasman W, Kindt M, van den Hout MA. A reaction time paradigm to assess (implicit) complaint-specific dysfunctional beliefs. Behaviour Res Therapy 2001, 39:101-113.
25. Beevers CG. Cognitive vulnerability to depression: A dual process model. Clin Psychol Review 2005, 25:975-1002.
26. Multidisciplinary Guidelines (Dutch). Guidelines Depression and Anxiety 2009
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a selfreported measure of medication adherence. Med Care 1986, 24:67-74. 10.1097/00005650-198601000-00007, 3945130.
28. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: Replication and exploration of differential relapse prevention effects. J Cons Clin Psychol 2004, 72:31-40.
29. Bockting CLH, Spinhoven P, Koeter MW, Wouters LF, Schene AH, . the DELTA study group Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability: a 2-year prospective study. J Clin Psychiatry 2006, 67(5):747-755. 10.4088/JCP.v67n0508, 16841624, the DELTA study group.
30. Spitzer RL, Williams JBW, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID 1) history, rationale, and description. Arch Gen Psychiatry 1992, 49(8):624-629.
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
32. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-86. 10.1017/S0033291700035558, 8733206.
33. Kraaij V, De Wilde EJ. Negative life events and depressive symptoms in the elderly: A life span perspective. Aging and Mental Health 2001, 5:84-91. 10.1080/13607860020020681, 11513018.
34. Franck E, De Raedt R, Barbez C, Rosseel Y. Psychometric properties of the Dutch Rosenberg self-esteem scale. Pscyhologica Belgica 2008, 48(1):25-35.
35. Akkerhuis GW, Kupka RW, van Groenestijn MAC, Nolen WA. PDQ-4+ Vragenlijst voor persoonlijkheidskenmerken 1996, Lisse: Swets & Zeitlinger.
36. van Hemert AM. Lichamelijke klachten vragenlijst 2003, Leids Universitair Medisch Centrum.
37. Vingerhoets AJJM, van Tilburg MAL. Everyday Problem Checklist (EPCL) 1994, Lisse: Swets & Zeitlinger B.V.
38. Angst J, Adolfsson R, Benazzi F, Gamma A, Hantouche E, Meyer TD, Skeppar P, Vieta E, Scott J. Towards the self-assessment tool for hypomanic symptoms in outpatients. J Affective Disorders 2005, 88:217-233.
39. Hakkaart-van Roijen L, van Straten A, Donker M, Tiemens B. Handleiding Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P) 2002, Instituut voor Medische Technology Assessment, Erasmus Universiteit Rotterdam.
40. EuroQol Group EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQol Group.
41. Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cogn Therapy Res 2003, 27:247-259.
42. Weissman AN. The Dysfunctional Attitude Scale. Academic dissertation 1979, University of Pennsylvania (Dissertation Abstracts International: 40, 1389B-1390B).
43. Van der Does W. Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther 2002, 40:105-20. 10.1016/S0005-7967(00)00111-X, 11762423.
44. Hayes SC, Strosahl KD, Wilson KG, Bissett RT, Pistorello J, Toarmino D, Polusny MA, Dykstra TA, Batten SV, Bergan J, Stewart SH, Zvolensky MJ, Eifert GH, Bond FW, Forsyth JP, Karekla M, Curry SM. Measuring Experiential Avoidance: A preliminary test of a working model. Psychol Record 2004, 54(4):553-578.
45. Schreurs PJG, Willige van den G, Brosschot JF, Tellegen B, Graus GMH. Herziene handleiding De Utrechtse Coping Lijst: UCL. Omgaan met problemen en gebeurtenissen 1993, Lisse: Swes & Zeitlinger.
46. First MB, Gibbon M, Spitzer RL, Williams JBW. User Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders. 1996, Washington, DC: American Psychiatric Association.
47. Greenwald AG, McGhee DE, Schwartz JLK. Measuring individual differences in implicit cognition. The Implicit Association Test. J Personality Social Psychol 1998, 74:1464-1480.
48. Koster EHW, De Raedt R, Verschuere B, Tibboel H, de Jong PJ. Enhanced emotioninduced attentional blink for negative information in dysphoria. Depression and Anxiety 2009, 26:16-22. 10.1002/da.20420, 18781666.
49. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Manual for cost studies, methods and standard prices for economic evaluation in health care [In Dutch: Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie] 2004, Amstelveen: Health Care Insurance Council.